National Guideline Clearinghouse | Teriflunomide for treating relapsing–remitting multiple sclerosis.

full-text ►

National Guideline Clearinghouse | Teriflunomide for treating relapsing–remitting multiple sclerosis.



National Institute for Health and Care Excellence (NICE)

Guideline Title

Teriflunomide for treating relapsing–remitting multiple sclerosis.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Teriflunomide for treating relapsing-remitting multiple sclerosis. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Jan. 57 p. (Technology appraisal guidance; no. 303).

Guideline Status

This is the current release of the guideline.